Private Trust Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Private Trust Company’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-120	Closed	-$2.83K	–	2475
2024 Q4	$2.83K	Sell	120 -30	-20%	-$738	﹤0.01%	2125
2024 Q3	$3.84K	Hold	150	–	–	﹤0.01%	2036
2024 Q2	$3.52K	Hold	150	–	–	﹤0.01%	2041
2024 Q1	$4.31K	Hold	150	–	–	﹤0.01%	1969
2023 Q4	$4.92K	Hold	150	–	–	﹤0.01%	1928
2023 Q3	$4.18K	Hold	150	–	–	﹤0.01%	1936
2023 Q2	$5.11K	Hold	150	–	–	﹤0.01%	1877
2023 Q1	$4.51K	Hold	150	–	–	﹤0.01%	1875
2022 Q4	$4K	Hold	150	–	–	﹤0.01%	1839
2022 Q3	$5K	Hold	150	–	–	﹤0.01%	1645
2022 Q2	$5K	Buy	+150	New	+$5.25K	﹤0.01%	1724

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Private Trust Company's ARKG Position: Q1 2025 in Review

Private Trust Company sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 120 shares — an estimated $2.83K sold.

Private Trust Company first reported a position in ARKG in Q2 2022 and held it in 11 quarters. The position peaked at $5.11K in Q2 2023. 217 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

Private Trust Company reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
Private Trust Company sold 120 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $2.83K.
Private Trust Company first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 11 quarters.
Private Trust Company's ARK Genomic Revolution ETF position peaked at $5.11K in Q2 2023.
217 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Private Trust Company's 13F filing for Q1 2025, filed 28 Apr 2025.